Cargando…

Immunotherapy in older patients with cancer

Ageing implicates a remodeling of our immune system, which is a consequence of the physiological senescence of our cells and tissues coupled with environmental factors and chronic antigen exposure. An immune system that senesces includes more differentiated cells with accumulation of highly differen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Granier, C., Gey, A., Roncelin, S., Weiss, L., Paillaud, E., Tartour, E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chang Gung University 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358190/ https://www.ncbi.nlm.nih.gov/pubmed/33041248 http://dx.doi.org/10.1016/j.bj.2020.07.009

Ejemplares similares

Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer
por: Granier, Clemence, et al.
Publicado: (2017)

Targeting Resident Memory T Cells for Cancer Immunotherapy
por: Blanc, Charlotte, et al.
Publicado: (2018)

Advances in Geriatric Oncology: Exploring Practical Ways to Optimize Treatment in Older Patients with Cancer
por: Paillaud, Elena, et al.
Publicado: (2022)

Immunotherapy of HPV-associated head and neck cancer: Critical parameters
por: Nizard, Mevyn, et al.
Publicado: (2013)

Perspectives on cancer care in older patients in France
por: Hauchecorne, Mathilde, et al.
Publicado: (2020)

Following up tumor-specific regulatory T cells in cancer patients
por: Zitvogel, Laurence, et al.
Publicado: (2013)

CXCR6 expressing T cells: Functions and role in the control of tumors
por: Mabrouk, Nesrine, et al.
Publicado: (2022)

Trial Watch: Adoptive cell transfer for anticancer immunotherapy
por: Vacchelli, Erika, et al.
Publicado: (2013)

Trial Watch: Adoptive cell transfer immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Absolute numbers of regulatory T cells and neutrophils in corticosteroid-free patients are predictive for response to bevacizumab in recurrent glioblastoma patients
por: Quillien, Véronique, et al.
Publicado: (2019)

Efficacy and Adverse Events of Immunotherapy with Checkpoint Inhibitors in Older Patients with Cancer
por: van Holstein, Yara, et al.
Publicado: (2019)

Prognostic Value of Prospective Longitudinal CRP to Albumin Ratio among Older Outpatients with Cancer
por: Burgassi, Fiamma, et al.
Publicado: (2021)

Serum Leptin Levels, Nutritional Status, and the Risk of Healthcare-Associated Infections in Hospitalized Older Adults
por: Paillaud, Elena, et al.
Publicado: (2022)

Prognostic value of comorbidities in older patients with cancer: the ELCAPA cohort study
por: Benderra, M.-A., et al.
Publicado: (2023)

Trial Watch: Adoptive cell transfer for anticancer immunotherapy
por: Aranda, Fernando, et al.
Publicado: (2014)

Molecular imaging for cancer immunotherapy
por: Lim, E.A., et al.
Publicado: (2020)

Taking care of older patients with cancer in the context of COVID-19 pandemic
por: Mourey, Loïc, et al.
Publicado: (2020)

An allogeneic NK cell line engineered to express chimeric antigen receptors: A novel strategy of cellular immunotherapy against cancer
por: Badoual, Cécile, et al.
Publicado: (2013)

The Pre-Operative GRADE Score Is Associated with 5-Year Survival among Older Patients with Cancer Undergoing Surgery
por: Wind, Philippe, et al.
Publicado: (2021)

Frailty Parameters, Morbidity and Mortality in Older Adults with Cancer: A Structural Equation Modelling Approach Based on the Fried Phenotype
por: Pamoukdjian, Frederic, et al.
Publicado: (2020)

Resident memory T cells, critical components in tumor immunology
por: Mami-Chouaib, Fathia, et al.
Publicado: (2018)

Unraveling Resistance to Immunotherapy in MSI-High Colorectal Cancer
por: Heregger, Ronald, et al.
Publicado: (2023)

Neurologic Complications of Cancer Immunotherapy
por: Alsalem, Aseel N., et al.
Publicado: (2023)

Development, validation and clinical impact of a prediction model for 6-month mortality in older cancer patients: the GRADE
por: Angeli, Eurydice, et al.
Publicado: (2020)

The Prognostic Value of Eight Comorbidity Indices in Older Patients with Cancer: The ELCAPA Cohort Study
por: Canoui-Poitrine, Florence, et al.
Publicado: (2022)

Cytokines in clinical cancer immunotherapy
por: Berraondo, Pedro, et al.
Publicado: (2018)

Cancer immunotherapy beyond immune checkpoint inhibitors
por: Marin-Acevedo, Julian A., et al.
Publicado: (2018)

PET/CT in Patients with Breast Cancer Treated with Immunotherapy
por: Vaz, Sofia C., et al.
Publicado: (2023)

Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment
por: Caillet, Philippe, et al.
Publicado: (2014)

Immunotherapy for Gastroesophageal Cancer
por: Goode, Emily F., et al.
Publicado: (2016)

Biological bases of cancer immunotherapy
por: Gonzales Carazas, Maryanne M., et al.
Publicado: (2021)

STxB as an Antigen Delivery Tool for Mucosal Vaccination
por: Tartour, Eric, et al.
Publicado: (2022)

Immunotherapy in older patients with non-small cell lung cancer: Young International Society of Geriatric Oncology position paper
por: Gomes, Fabio, et al.
Publicado: (2020)

Overall Survival and Prognostic Factors among Older Patients with Metastatic Pancreatic Cancer: A Retrospective Analysis Using a Hospital Database
por: Conti, Catherine, et al.
Publicado: (2022)

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers
por: Wolf, Gregory T, et al.
Publicado: (2018)

Immunotherapy in Oral Cancer
por: Mohan, Sunil Paramel, et al.
Publicado: (2019)

Magnetic systems for cancer immunotherapy
por: Day, Nicole B., et al.
Publicado: (2021)

Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer
por: Bansal, Dhruv, et al.
Publicado: (2021)

The Immune Microenvironment in Penile Cancer and Rationale for Immunotherapy
por: Ahmed, Mohamed E., et al.
Publicado: (2020)

Talkin’ Toxins: From Coley’s to Modern Cancer Immunotherapy
por: Carlson, Robert D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i976gml1dusikpmhdhfhk21pht